Invesco’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $561K | Sell |
20,289
-13,203
| -39% | -$365K | ﹤0.01% | 3105 |
|
|
2025
Q1 | $744K | Buy |
33,492
+19,384
| +137% | +$431K | ﹤0.01% | 2957 |
|
|
2024
Q4 | $279K | Sell |
14,108
-41,380
| -75% | -$818K | ﹤0.01% | 3417 |
|
|
2024
Q3 | $1.39M | Buy |
+55,488
| New | +$1.39M | ﹤0.01% | 2767 |
|
|
2024
Q2 | – | Sell |
-54,320
| Closed | -$1.07M | – | 3911 |
|
|
2024
Q1 | $1.07M | Buy |
54,320
+41,678
| +330% | +$822K | ﹤0.01% | 2949 |
|
|
2023
Q4 | $222K | Sell |
12,642
-199,954
| -94% | -$3.51M | ﹤0.01% | 3530 |
|
|
2023
Q3 | $3.69M | Buy |
+212,596
| New | +$3.69M | ﹤0.01% | 2351 |
|
|
2023
Q2 | – | Sell |
-13,109
| Closed | -$141K | – | 3884 |
|
|
2023
Q1 | $141K | Sell |
13,109
-200,449
| -94% | -$2.16M | ﹤0.01% | 3656 |
|
|
2022
Q4 | $3.2M | Buy |
213,558
+199,703
| +1,441% | +$2.99M | ﹤0.01% | 2445 |
|
|
2022
Q3 | $178K | Buy |
13,855
+1,622
| +13% | +$20.8K | ﹤0.01% | 3693 |
|
|
2022
Q2 | $118K | Buy |
12,233
+837
| +7% | +$8.07K | ﹤0.01% | 3830 |
|
|
2022
Q1 | $113K | Buy |
11,396
+156
| +1% | +$1.55K | ﹤0.01% | 3821 |
|
|
2021
Q4 | $133K | Sell |
11,240
-1,496
| -12% | -$17.7K | ﹤0.01% | 3823 |
|
|
2021
Q3 | $145K | Buy |
12,736
+1,751
| +16% | +$19.9K | ﹤0.01% | 3839 |
|
|
2021
Q2 | $153K | Buy |
+10,985
| New | +$153K | ﹤0.01% | 3807 |
|
|
2020
Q3 | – | Sell |
-50,074
| Closed | -$1.28M | – | 3622 |
|
|
2020
Q2 | $1.28M | Buy |
+50,074
| New | +$1.28M | ﹤0.01% | 2672 |
|
|
2019
Q1 | – | Sell |
-44,363
| Closed | -$1.25M | – | 3705 |
|
|
2018
Q4 | $1.25M | Buy |
+44,363
| New | +$1.25M | ﹤0.01% | 2827 |
|